Caris Life Sciences, Inc. (CAI)
26.13
-0.14
(-0.53%)
USD |
NASDAQ |
Aug 24, 16:00
26.12
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Total Liabilities (Quarterly) : 637.89M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 637.89M |
| March 31, 2026 | 568.90M |
| December 31, 2025 | 548.36M |
| September 30, 2025 | 506.21M |
| Date | Value |
|---|---|
| June 30, 2025 | 502.15M |
| March 31, 2025 | 645.34M |
| December 31, 2024 | 620.92M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CareDx, Inc. | 107.39M |
| Myriad Genetics, Inc. | 335.00M |
| BioRestorative Therapies, Inc. | 1.615M |
| Natera, Inc. | 836.00M |
| Exagen, Inc. | 39.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.230B |
| Shareholders Equity (Quarterly) | 591.73M |
| Debt to Equity Ratio | 0.7645 |
| Current Ratio | 5.526 |
| Net Debt Paydown Yield | -0.13% |